Author Archives: ene057

Welcome back!

Per BakkeI hope you all had a nice summer, and that you have had the chance to recharge your batteries and are ready for new achievements this autumn.
The department has a new administration manager, Julie Stavnes. She used to work in the oil industry, and will be able to see the department administration with fresh eyes. A detailed presentation of her can be found elsewhere in this issue.
Eva Gerdts has resigned as program coordinator after putting in a huge effort over several years, and is replaced by Jone Trovik from the gyn / obs environment.

This autumn there are several important issues for the department. The current strategic plan for K2 expires this year. We need to evaluate to what extent we have reached the goals we set and, not least, prepare a new one. The K2 organization will be adjusted.
The implementation of the new curriculum in medicine is to be implemented.
The focus on applications for external projects must be encouraged.
And not least the tight economy is a theme.I report that K2’s economy is improving. I will come backk to these and other matters later.
Per

K2 paper in NEJM

SimSimon E. Nitter Dankelon Dankel (pictured), Christine Haugen, Gunnar Mellgren and others at K2/the Hormon Laboratoy have participated in a study that was published in New England Journal of Medicine Wednesday evening.
The study describes how a common genetic obesity-variant in the FTO-gene region alters the energy metabolism directly in fat cells, and which genes and proteins that are involved in this new mechanism. Using the FTO-variant as an example, the study presents new  comprehensive strategies to explore and understand the mechanisms of regulatory genetic variants in non-coding DNA, which gives hope of finding a number of new targets for personalized treatment of common                                                                       diseases in the decades to come.

Photo: Jørgen Barth

Happy summer!

SummPer Bakkeer is approaching and this is the last K2Nytt before the holiday. It has been a hectic half-year. When it comes to research, it should be mentioned that K2 since 2014 is the department at UiB with most EU applications, the number is 24, out of which 5 have been granted, one of them a coordinator project, the only one at UiB. We are still awaiting results on 11 of the applications. This shows that EU applications are worthwhile.

When it comes to teaching, the work on the new curriculum in medicine has been central. There is still much work to be done. It should also be noted that the pharmacy study has worked towards beginning an education in galenic pharmacy, which will start this fall.

Economically things are tight, but we keep to the budget and there is a realistic plan to pay down our debt of approximately NOK 3 million within a few years.

Various important issues this fall are a new organization of K2, work on a new strategy for the department, and not least the new curriculum in addition to focusing on external funding. But now it’s a well-deserved vacation around the corner. Thank you all for your efforts, and have a Great Summer!

Per

Be good ambassadors of enthusiasm!

SMDuring my period at K2 I have yet to come across a colleague who is not great and dedicated, either they have been research fellows, post doctorates, scientists, technicians, administrative staff or professors.

There is a staggering amount of competence at our institute. The infrastructure is good, and eventually all the different departments will be able to move into new sites.

With the good conditions, it has been truly inspiring to see the first results of K2´s new structure. One of the measuring parameters especially interesting to me is the increase in applicants. In the planning process we thought we were ambitious in our estimates of contributors to increase by 30 %. The most recent calculations show an increase of 45%. This is a clear sign of the difference all of you make every day -you made it happen! You are a force to be reckoned with, in a competitive international arena.

It’s sad then, when the focus is on contribution margins, when we should be celebrating our results which are science and research led. Contribution margins are governed by politicians, and an important component of the financing of our institute. However, the decisions are led by politicians, while the institute management can focus on influencing (politicians), and argue in favour of full finance packets, in those arenas available to us.

Within the field of teaching K2 has shown its credentials, winning multiple prices and awards, we have dedicated teachers strategically placed in the new semester board, these are important premise providers of future education within the field of medicine.

Talk each other up! You’re only as good as the company you keep, therefore cheer your colleagues on. I find that the best reward is rather accolades from a colleague, than an acquaintance. Motivate each other, work is so much more fun smiling. If it doesn’t quite go to plan, make sure you have each others backs. The support you can give a colleague is invaluable for the work environment.
It’s a fact. All scientists have been rejected at some point, it helps up and coming scientist if you share your experience, help them along by not giving up.

A hope I know I share with many of you, is to recruit more women scientists. The female share is embarrassingly low, so here’s my cry of hope for the future: get more of those brilliant women here!

I wish you all the best of luck with all your exciting projects, the new study schedule within farmacy and medicine the coming years. It’s been a great joy to be a part of K2. New (and greener) pastures await me at the institute of Biology. I do hope we can find projects to work for both institutes in the future. You are all welcome to visit me at Marineholmen.

Enjoy your weekend,
Kindly,
Synnøve